{"entity":{"type":"insider","cik":"0001383391","url":"/insider/0001383391","json_url":"/insider/0001383391.json","name":"New Enterprise Associates 12, Limited Partnership","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":29,"first":"2009-03-20","last":"2019-11-29","span_basis":"filed_date"},"name_variants":[{"name":"New Enterprise Associates 12, Limited Partnership","source":"filing","n_filings":29,"first_seen":"2009-03-20","last_seen":"2019-11-29"}],"transactions":[{"id":8069611,"accession":"0001209191-19-058418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-058418","line_url":"/filing/0001209191-19-058418#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BASKETT FOREST; SANDELL SCOTT D; BARRIS PETER J; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; KERINS PATRICK J","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1166755.0,"shares_display":"1,166,755","price_per_share":2.5213,"price_display":"2.52","price_state":"stated","total_value":2941739.3815,"total_display":"2,941,739.38","total_whole":"2,941,739","shares_owned_after":4270691.0,"shares_owned_after_display":"4,270,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-11-29","scope":"insider"},{"id":8069606,"accession":"0001209191-19-058418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058418","line_url":"/filing/0001209191-19-058418#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BASKETT FOREST; SANDELL SCOTT D; BARRIS PETER J; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; KERINS PATRICK J","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117164.0,"shares_display":"117,164","price_per_share":2.4507,"price_display":"2.45","price_state":"stated","total_value":287133.8148,"total_display":"287,133.81","total_whole":"287,134","shares_owned_after":5437446.0,"shares_owned_after_display":"5,437,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-11-29","scope":"insider"},{"id":6455605,"accession":"0001209191-18-044777","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-044777","line_url":"/filing/0001209191-18-044777#line-4","is_derivative":false,"issuer_cik":"0001330436","issuer_name":"Liquidia Technologies Inc","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001330436","owner_cik":null,"owner_name":"NEA Partners 12, Limited Partnership; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC","owner_display_name":"NEA Partners 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":545455.0,"shares_display":"545,455","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":6000005.0,"total_display":"6,000,005.00","total_whole":"6,000,005","shares_owned_after":2484870.0,"shares_owned_after_display":"2,484,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-08-01","scope":"insider"},{"id":4874264,"accession":"0001209191-17-066249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066249","line_url":"/filing/0001209191-17-066249#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BASKETT FOREST; NEA Partners 12, Limited Partnership; SANDELL SCOTT D; BARRIS PETER J; KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":5554610.0,"shares_owned_after_display":"5,554,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-19","scope":"insider"},{"id":4358807,"accession":"0001209191-17-044680","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-17-044680","line_url":"/filing/0001209191-17-044680#line-7","is_derivative":false,"issuer_cik":"0001383391","issuer_name":"Tintri, Inc.","issuer_ticker":"TNTR","issuer_name_source":null,"issuer_url":"/issuer/0001383391","owner_cik":"0001383391","owner_name":"New Enterprise Associates 12, Limited Partnership","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":"/insider/0001383391","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":926429.0,"shares_display":"926,429","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":6485003.0,"total_display":"6,485,003.00","total_whole":"6,485,003","shares_owned_after":5248359.0,"shares_owned_after_display":"5,248,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-06","filed_date":"2017-07-10","scope":"insider"},{"id":4312099,"accession":"0001209191-17-010557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-010557","line_url":"/filing/0001209191-17-010557#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"SANDELL SCOTT D; KERINS PATRICK J; BARRIS PETER J; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST","owner_display_name":"SANDELL SCOTT D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1099996.0,"shares_display":"1,099,996","price_per_share":2.0104,"price_display":"2.01","price_state":"stated","total_value":2211431.9584,"total_display":"2,211,431.96","total_whole":"2,211,432","shares_owned_after":952809.0,"shares_owned_after_display":"952,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-13","filed_date":"2017-02-14","scope":"insider"},{"id":2596047,"accession":"0001209191-16-142163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-142163","line_url":"/filing/0001209191-16-142163#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KOLLURI KRISHNA KITTU; BARRIS PETER J; KERINS PATRICK J; BASKETT FOREST; SANDELL SCOTT D; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership","owner_display_name":"KOLLURI KRISHNA KITTU","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7471.0,"shares_display":"7,471","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":5603.25,"total_display":"5,603.25","total_whole":"5,603","shares_owned_after":2052805.0,"shares_owned_after_display":"2,052,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-20","scope":"insider"},{"id":2962160,"accession":"0001209191-16-141608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-141608","line_url":"/filing/0001209191-16-141608#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BASKETT FOREST; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; SANDELL SCOTT D; BARRIS PETER J; KOLLURI KRISHNA KITTU; KERINS PATRICK J; NEA Partners 12, Limited Partnership","owner_display_name":"BASKETT FOREST","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":461538.0,"shares_display":"461,538","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":3554610.0,"shares_owned_after_display":"3,554,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-15","scope":"insider"},{"id":2595936,"accession":"0001209191-16-141605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-141605","line_url":"/filing/0001209191-16-141605#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KOLLURI KRISHNA KITTU; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; KERINS PATRICK J; SANDELL SCOTT D; BARRIS PETER J; NEA Partners 12, Limited Partnership; BASKETT FOREST","owner_display_name":"KOLLURI KRISHNA KITTU","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":7400.0,"total_display":"7,400.00","total_whole":"7,400","shares_owned_after":2060276.0,"shares_owned_after_display":"2,060,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-15","scope":"insider"},{"id":3320659,"accession":"0001209191-16-139316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-139316","line_url":"/filing/0001209191-16-139316#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"NEA 12 GP, LLC; BARRIS PETER J; New Enterprise Associates 12, Limited Partnership; KERINS PATRICK J; NEA Partners 12, Limited Partnership; SANDELL SCOTT D; KOLLURI KRISHNA KITTU; BASKETT FOREST","owner_display_name":"NEA 12 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":1.0088,"price_display":"1.01","price_state":"stated","total_value":50440.0,"total_display":"50,440.00","total_whole":"50,440","shares_owned_after":2070276.0,"shares_owned_after_display":"2,070,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-29","filed_date":"2016-08-31","scope":"insider"},{"id":3085758,"accession":"0001209191-16-138820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-138820","line_url":"/filing/0001209191-16-138820#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; KERINS PATRICK J; BASKETT FOREST; KOLLURI KRISHNA KITTU; BARRIS PETER J; NEA Partners 12, Limited Partnership; SANDELL SCOTT D","owner_display_name":"NEA 12 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":1452.0,"total_display":"1,452.00","total_whole":"1,452","shares_owned_after":2120276.0,"shares_owned_after_display":"2,120,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-24","filed_date":"2016-08-26","scope":"insider"},{"id":2960547,"accession":"0001209191-16-133608","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-133608","line_url":"/filing/0001209191-16-133608#line-3","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; KOLLURI KRISHNA KITTU; NEA Partners 12, Limited Partnership; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8989.0,"shares_display":"8,989","price_per_share":1.3302,"price_display":"1.33","price_state":"stated","total_value":11957.1678,"total_display":"11,957.17","total_whole":"11,957","shares_owned_after":2121476.0,"shares_owned_after_display":"2,121,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-21","filed_date":"2016-07-21","scope":"insider"},{"id":2960545,"accession":"0001209191-16-133608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-133608","line_url":"/filing/0001209191-16-133608#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; KOLLURI KRISHNA KITTU; NEA Partners 12, Limited Partnership; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14158.0,"shares_display":"14,158","price_per_share":1.2396,"price_display":"1.24","price_state":"stated","total_value":17550.2568,"total_display":"17,550.26","total_whole":"17,550","shares_owned_after":2130465.0,"shares_owned_after_display":"2,130,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-20","filed_date":"2016-07-21","scope":"insider"},{"id":2960540,"accession":"0001209191-16-133608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-133608","line_url":"/filing/0001209191-16-133608#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; KOLLURI KRISHNA KITTU; NEA Partners 12, Limited Partnership; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":534.0,"shares_display":"534","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":624.78,"total_display":"624.78","total_whole":"625","shares_owned_after":2144623.0,"shares_owned_after_display":"2,144,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-19","filed_date":"2016-07-21","scope":"insider"},{"id":2371647,"accession":"0001209191-16-133479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-133479","line_url":"/filing/0001209191-16-133479#line-1","is_derivative":false,"issuer_cik":"0001383389","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001383389","owner_cik":null,"owner_name":"NEA 12 GP, LLC; NEA Partners 12, Limited Partnership; New Enterprise Associates 12, Limited Partnership","owner_display_name":"NEA 12 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":763650.0,"shares_display":"763,650","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":6666664.5,"total_display":"6,666,664.50","total_whole":"6,666,665","shares_owned_after":8752543.0,"shares_owned_after_display":"8,752,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-18","filed_date":"2016-07-20","scope":"insider"},{"id":2700994,"accession":"0001209191-16-132900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-132900","line_url":"/filing/0001209191-16-132900#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; SANDELL SCOTT D; KOLLURI KRISHNA KITTU; BARRIS PETER J; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13382.0,"shares_display":"13,382","price_per_share":1.2001,"price_display":"1.20","price_state":"stated","total_value":16059.7382,"total_display":"16,059.74","total_whole":"16,060","shares_owned_after":2145157.0,"shares_owned_after_display":"2,145,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-13","filed_date":"2016-07-15","scope":"insider"},{"id":2696174,"accession":"0001209191-16-099506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-099506","line_url":"/filing/0001209191-16-099506#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KOLLURI KRISHNA KITTU; KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership; BASKETT FOREST","owner_display_name":"KOLLURI KRISHNA KITTU","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900324.0,"shares_display":"900,324","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7202592.0,"total_display":"7,202,592.00","total_whole":"7,202,592","shares_owned_after":3093072.0,"shares_owned_after_display":"3,093,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-17","scope":"insider"},{"id":2233277,"accession":"0001209191-16-091421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091421","line_url":"/filing/0001209191-16-091421#line-1","is_derivative":false,"issuer_cik":"0001383389","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001383389","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":7988893.0,"shares_owned_after_display":"7,988,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-13","filed_date":"2016-01-14","scope":"insider"},{"id":8863624,"accession":"0001181431-15-008044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-15-008044","line_url":"/filing/0001181431-15-008044#line-1","is_derivative":false,"issuer_cik":"0001383389","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001383389","owner_cik":null,"owner_name":"NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"NEA 12 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1869159.0,"shares_display":"1,869,159","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":20000001.3,"total_display":"20,000,001.30","total_whole":"20,000,001","shares_owned_after":7488893.0,"shares_owned_after_display":"7,488,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-05","filed_date":"2015-06-09","scope":"insider"},{"id":8931920,"accession":"0001181431-15-001720","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-001720","line_url":"/filing/0001181431-15-001720#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BARRIS PETER J; DRANT RYAN D; SANDELL SCOTT D; KOLLURI KRISHNA KITTU; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership; KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST","owner_display_name":"BARRIS PETER J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23457.0,"shares_display":"23,457","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":258027.0,"total_display":"258,027.00","total_whole":"258,027","shares_owned_after":2158539.0,"shares_owned_after_display":"2,158,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-30","filed_date":"2015-02-02","scope":"insider"},{"id":6463390,"accession":"0001181431-14-038451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-038451","line_url":"/filing/0001181431-14-038451#line-1","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; BASKETT FOREST; New Enterprise Associates 12, Limited Partnership; KOLLURI KRISHNA KITTU; SANDELL SCOTT D; BARRETT M JAMES; KERINS PATRICK J; DRANT RYAN D; BARRIS PETER J","owner_display_name":"NEA Partners 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":4811691.0,"shares_owned_after_display":"4,811,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-10","scope":"insider"},{"id":6642362,"accession":"0001181431-14-030566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-3","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11600.0,"shares_display":"11,600","price_per_share":7.506,"price_display":"7.51","price_state":"stated","total_value":87069.6,"total_display":"87,069.60","total_whole":"87,070","shares_owned_after":4659333.0,"shares_owned_after_display":"4,659,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-29","filed_date":"2014-08-29","scope":"insider"},{"id":6642355,"accession":"0001181431-14-030566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146800.0,"shares_display":"146,800","price_per_share":7.8668,"price_display":"7.87","price_state":"stated","total_value":1154846.24,"total_display":"1,154,846.24","total_whole":"1,154,846","shares_owned_after":4670933.0,"shares_owned_after_display":"4,670,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-28","filed_date":"2014-08-29","scope":"insider"},{"id":6642350,"accession":"0001181431-14-030566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108300.0,"shares_display":"108,300","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":884811.0,"total_display":"884,811.00","total_whole":"884,811","shares_owned_after":4817733.0,"shares_owned_after_display":"4,817,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":7066890,"accession":"0001181431-14-028995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-028995","line_url":"/filing/0001181431-14-028995#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35540.0,"shares_display":"35,540","price_per_share":6.7583,"price_display":"6.76","price_state":"stated","total_value":240189.982,"total_display":"240,189.98","total_whole":"240,190","shares_owned_after":4926033.0,"shares_owned_after_display":"4,926,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":7066888,"accession":"0001181431-14-028995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-028995","line_url":"/filing/0001181431-14-028995#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675000.0,"shares_display":"675,000","price_per_share":6.6201,"price_display":"6.62","price_state":"stated","total_value":4468567.5,"total_display":"4,468,567.50","total_whole":"4,468,568","shares_owned_after":4961573.0,"shares_owned_after_display":"4,961,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-08","filed_date":"2014-08-12","scope":"insider"},{"id":6782251,"accession":"0001181431-14-025055","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-025055","line_url":"/filing/0001181431-14-025055#line-5","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BARRIS PETER J; SANDELL SCOTT D; DRANT RYAN D; KERINS PATRICK J; New Enterprise Associates 12, Limited Partnership; BARRETT M JAMES; NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; KOLLURI KRISHNA KITTU; BASKETT FOREST","owner_display_name":"BARRIS PETER J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":510442.0,"shares_display":"510,442","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7146188.0,"total_display":"7,146,188.00","total_whole":"7,146,188","shares_owned_after":6619734.0,"shares_owned_after_display":"6,619,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2014-06-26","scope":"insider"},{"id":6430280,"accession":"0001181431-14-016851","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-14-016851","line_url":"/filing/0001181431-14-016851#line-6","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"TriVascular Technologies, Inc.","issuer_ticker":"TRIV","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"KERINS PATRICK J; BARRETT M JAMES; BARRIS PETER J; SANDELL SCOTT D; NEA Partners 12, Limited Partnership; New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; KOLLURI KRISHNA KITTU; NEA 12 GP, LLC","owner_display_name":"KERINS PATRICK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":583333.0,"shares_display":"583,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6999996.0,"total_display":"6,999,996.00","total_whole":"6,999,996","shares_owned_after":583333.0,"shares_owned_after_display":"583,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-22","filed_date":"2014-04-24","scope":"insider"},{"id":6253333,"accession":"0001181431-14-005688","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-005688","line_url":"/filing/0001181431-14-005688#line-2","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"BARRETT M JAMES; DRANT RYAN D; KERINS PATRICK J; NEA 12 GP, LLC; BARRIS PETER J; SANDELL SCOTT D; KOLLURI KRISHNA KITTU; BASKETT FOREST; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"BARRETT M JAMES","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":472410.0,"shares_display":"472,410","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3306870.0,"total_display":"3,306,870.00","total_whole":"3,306,870","shares_owned_after":3811691.0,"shares_owned_after_display":"3,811,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-07","scope":"insider"},{"id":5110911,"accession":"0001181431-13-058742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-058742","line_url":"/filing/0001181431-13-058742","is_derivative":false,"issuer_cik":"0001005561","issuer_name":"CHANNELADVISOR CORP","issuer_ticker":"ECOM","issuer_name_source":null,"issuer_url":"/issuer/0001005561","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; BASKETT FOREST; NEA 12 GP, LLC; BARRIS PETER J; SANDELL SCOTT D; KOLLURI KRISHNA KITTU; DRANT RYAN D; BARRETT M JAMES; NEA Partners 12, Limited Partnership","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1104241.0,"shares_display":"1,104,241","price_per_share":32.37,"price_display":"32.37","price_state":"stated","total_value":35744281.17,"total_display":"35,744,281.17","total_whole":"35,744,281","shares_owned_after":1862369.0,"shares_owned_after_display":"1,862,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-12","filed_date":"2013-11-13","scope":"insider","n_lines":2},{"id":2688282,"accession":"0001181431-12-043183","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001181431-12-043183","line_url":"/filing/0001181431-12-043183#line-9","is_derivative":false,"issuer_cik":"0001383389","issuer_name":"HYPERION THERAPEUTICS INC","issuer_ticker":"HPTX","issuer_name_source":null,"issuer_url":"/issuer/0001383389","owner_cik":null,"owner_name":"NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership","owner_display_name":"NEA Partners 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2884221.0,"shares_owned_after_display":"2,884,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-31","filed_date":"2012-08-02","scope":"insider"},{"id":8965738,"accession":"0001181431-11-057939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057939","line_url":"/filing/0001181431-11-057939#line-1","is_derivative":false,"issuer_cik":"0001383389","issuer_name":"FUSION-IO, INC.","issuer_ticker":"FIO","issuer_name_source":null,"issuer_url":"/issuer/0001383389","owner_cik":null,"owner_name":"NEA Partners 12, Limited Partnership; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership","owner_display_name":"NEA Partners 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1291493.0,"shares_display":"1,291,493","price_per_share":31.68,"price_display":"31.68","price_state":"stated","total_value":40914498.24,"total_display":"40,914,498.24","total_whole":"40,914,498","shares_owned_after":24538379.0,"shares_owned_after_display":"24,538,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-28","filed_date":"2011-11-30","scope":"insider"},{"id":8939765,"accession":"0001181431-11-017713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017713","line_url":"/filing/0001181431-11-017713#line-1","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"ARYx Therapeutics, Inc.","issuer_ticker":"ARYX","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"PERRY MARK W; NEA 12 GP, LLC; Growth Equity Opportunities Fund, LLC; NEA Partners 12, Limited Partnership; SANDELL SCOTT D; BARRETT M JAMES; NEWHALL CHARLES W III; New Enterprise Associates 12, Limited Partnership; KRAMLICH C RICHARD; BARRIS PETER J","owner_display_name":"PERRY MARK W","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4469274.0,"shares_display":"4,469,274","price_per_share":0.073,"price_display":"0.07","price_state":"stated","total_value":326257.002,"total_display":"326,257.00","total_whole":"326,257","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-14","scope":"insider"},{"id":7666938,"accession":"0001181431-10-035797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-035797","line_url":"/filing/0001181431-10-035797#line-2","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership; KRAMLICH C RICHARD; NEWHALL CHARLES W III; BARRIS PETER J; PERRY MARK W; BARRETT M JAMES; SANDELL SCOTT D; Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23824451.0,"shares_display":"23,824,451","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":6551724.025,"total_display":"6,551,724.02","total_whole":"6,551,724","shares_owned_after":23824451.0,"shares_owned_after_display":"23,824,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider"},{"id":5678451,"accession":"0001181431-09-016730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-016730","line_url":"/filing/0001181431-09-016730#line-2","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; NEWHALL CHARLES W III; BARRETT M JAMES; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC; KRAMLICH C RICHARD; PERRY MARK W; TRAINOR III EUGENE A; NEA Partners 12, Limited Partnership","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5218.55,"shares_display":"5,218.55","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":2557.0895,"total_display":"2,557.09","total_whole":"2,557","shares_owned_after":1301781.55,"shares_owned_after_display":"1,301,781.55","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-11","filed_date":"2009-03-20","scope":"insider"},{"id":5678450,"accession":"0001181431-09-016730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-016730","line_url":"/filing/0001181431-09-016730#line-1","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; NEWHALL CHARLES W III; BARRETT M JAMES; BARRIS PETER J; SANDELL SCOTT D; NEA 12 GP, LLC; KRAMLICH C RICHARD; PERRY MARK W; TRAINOR III EUGENE A; NEA Partners 12, Limited Partnership","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","total_whole":"4,900","shares_owned_after":1296563.0,"shares_owned_after_display":"1,296,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-10","filed_date":"2009-03-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Ten percent owner","n_filings":4,"first_seen":"2016-02-17","last_seen":"2019-11-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001330436","name":"Liquidia Technologies Inc","url":"/issuer/0001330436","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-01","last_seen":"2018-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001554875","name":"Tintri, Inc.","url":"/issuer/0001554875","role":"Ten percent owner","n_filings":1,"first_seen":"2017-07-10","last_seen":"2017-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001587221","name":"Zosano Pharma Corp","url":"/issuer/0001587221","role":"Ten percent owner","n_filings":8,"first_seen":"2015-02-02","last_seen":"2017-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001437402","name":"ARDELYX, INC.","url":"/issuer/0001437402","role":"Ten percent owner","n_filings":4,"first_seen":"2014-06-26","last_seen":"2016-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Ten percent owner","n_filings":2,"first_seen":"2014-02-07","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Ten percent owner","n_filings":3,"first_seen":"2010-07-02","last_seen":"2014-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001432732","name":"TriVascular Technologies, Inc.","url":"/issuer/0001432732","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-24","last_seen":"2014-04-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001169652","name":"CHANNELADVISOR CORP","url":"/issuer/0001169652","role":"Ten percent owner","n_filings":1,"first_seen":"2013-11-13","last_seen":"2013-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001386858","name":"HYPERION THERAPEUTICS INC","url":"/issuer/0001386858","role":"Ten percent owner","n_filings":1,"first_seen":"2012-08-02","last_seen":"2012-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001383729","name":"FUSION-IO, INC.","url":"/issuer/0001383729","role":"Ten percent owner","n_filings":1,"first_seen":"2011-11-30","last_seen":"2011-11-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001410064","name":"ARYx Therapeutics, Inc.","url":"/issuer/0001410064","role":"Ten percent owner","n_filings":1,"first_seen":"2011-03-14","last_seen":"2011-03-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001408808","name":"PEPLIN INC","url":"/issuer/0001408808","role":"Ten percent owner","n_filings":1,"first_seen":"2009-03-20","last_seen":"2009-03-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001383391","retrieved_at":"2026-08-23T05:26:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}